Department of Surgery, Thomas Jefferson University, Philadelphia, Pa.
Department of Surgery, Thomas Jefferson University, Philadelphia, Pa.
J Thorac Cardiovasc Surg. 2015 Nov;150(5):1344-9. doi: 10.1016/j.jtcvs.2015.07.061. Epub 2015 Jul 26.
Despite advances in medical care, survival to discharge and full neurologic recovery after cardiac arrest remains less than 20% after cardiopulmonary resuscitation. An alternate approach to traditional cardiopulmonary resuscitation is extracorporeal cardiopulmonary resuscitation, which places patients on extracorporeal membrane oxygenation during cardiopulmonary resuscitation and provides immediate cardiopulmonary support when traditional resuscitation has been unsuccessful. We report the results from extracorporeal cardiopulmonary resuscitation at the Thomas Jefferson University.
Between 2010 and June 2014, 107 adult extracorporeal membrane oxygenation procedures were performed at the Thomas Jefferson University. Patient demographics, survival to discharge, and neurologic recovery of patients who underwent extracorporeal cardiopulmonary resuscitation were retrospectively analyzed with institutional review board approval.
A total of 23 patients (15 male and 8 female; mean age, 46 ± 12 years) underwent extracorporeal cardiopulmonary resuscitation. All patients who met criteria were placed on 24-hour hypothermia protocol (target temperature 33°C) with initiation of extracorporeal membrane oxygenation. The mean duration of extracorporeal membrane oxygenation support was 6.2 ± 5.5 days. Nine patients died while on extracorporeal membrane oxygenation from the following causes: anoxic brain injury (4), stroke (4), and bowel necrosis (1). Two patients with anoxic brain injury on extracorporeal cardiopulmonary resuscitation donated multiple organs for transplant. The survival to discharge was 30% (7/23 patients) with approximately 100% full neurologic recovery.
The extracorporeal cardiopulmonary resuscitation procedure provided reasonable patient recovery. Extracorporeal cardiopulmonary resuscitation also allowed for neurologic recovery and made multiorgan procurement possible. On the basis of the survival, extracorporeal cardiopulmonary resuscitation should be considered when determining the optimal treatment path for patients who need cardiopulmonary resuscitation. The proper use of extracorporeal cardiopulmonary resuscitation improved the hospital outcomes for patients with in-hospital cardiac arrest.
尽管医疗技术取得了进步,但心肺复苏后能出院并完全恢复神经功能的患者存活率仍不足 20%。心肺复苏的另一种方法是体外心肺复苏,即在心肺复苏期间将患者置于体外膜肺氧合(ECMO)下,并在传统复苏失败时立即提供心肺支持。我们报告了托马斯·杰斐逊大学(Thomas Jefferson University)进行体外心肺复苏的结果。
在 2010 年至 2014 年 6 月期间,托马斯·杰斐逊大学共进行了 107 例成人 ECMO 手术。经机构审查委员会批准,回顾性分析了接受体外心肺复苏患者的患者人口统计学、出院存活率和神经恢复情况。
共有 23 名患者(15 名男性和 8 名女性;平均年龄 46 ± 12 岁)接受了体外心肺复苏。所有符合条件的患者均接受 24 小时低温方案(目标温度 33°C),并开始进行 ECMO。ECMO 支持的平均持续时间为 6.2 ± 5.5 天。9 名患者在 ECMO 期间因以下原因死亡:缺氧性脑损伤(4 例)、中风(4 例)和肠坏死(1 例)。2 名体外心肺复苏后发生缺氧性脑损伤的患者捐赠了多个器官进行移植。出院存活率为 30%(23 例患者中有 7 例),约 100%完全恢复神经功能。
体外心肺复苏程序为患者提供了合理的恢复机会。体外心肺复苏还可以实现神经恢复,并使多器官获取成为可能。基于存活率,对于需要心肺复苏的患者,应考虑体外心肺复苏以确定最佳治疗路径。体外心肺复苏的正确使用改善了院内心脏骤停患者的医院转归。